A Randomized, Placebo-controlled, Blinded Phase II Study of Huachansu and Gemcitabine in Pancreatic Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Herbal medicines; Traditional Chinese medicine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 12 Jul 2012 Biomarkers information updated
- 11 Jul 2012 Actual end date Jul 2012 added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.